The global Transforming Growth Factor Beta 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Transforming Growth Factor Beta 2 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transforming Growth Factor Beta 2 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Transforming Growth Factor Beta 2 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Transforming Growth Factor Beta 2 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Autotelic Inc
Genzyme Corp
Isarna Therapeutics GmbH
Novartis AG
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
XOMA-089
Trabedersen
ISTH-0047
Others

Segment by Application
Glioblastoma Multiforme
Open-Angle Glaucoma
Liver Fibrosis
Melanoma
Breast Cancer
Others